Provided by Tiger Trade Technology Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

77.60
-0.4850-0.62%
Volume:209.09K
Turnover:16.23M
Market Cap:6.05B
PE:78.38
High:78.36
Open:78.00
Low:76.65
Close:78.08
52wk High:82.94
52wk Low:33.45
Shares:78.02M
Float Shares:40.20M
Volume Ratio:0.63
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9900
EPS(LYR):0.7500
ROE:14.04%
ROA:8.05%
PB:9.26
PE(LYR):103.46

Loading ...

Jun 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 29, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2025

Major Issues Report

Form 8-K - Current report